Skip to main content
OpenTrials

Clinical trial condition

Digestive System Neoplasms

Explore clinical trials studying Digestive System Neoplasms. Study availability and eligibility vary by location and protocol.

14,203 public trials 3,225 recruiting studies
Refine in advanced search Browse all conditions

Digestive System Neoplasms trial results

Active, Not Recruiting

Claudin 18.2-Targeted Chimeric Antigen Receptor T-cells in Subjects With Unresectable, Locally Advanced, or Metastatic Gastric, Gastroesophageal Junction (GEJ), Esophageal, or Pancreatic Adenocarcinoma

NCT05539430

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +16 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • John Theurer Cancer Center at HackensackUMC Hackensack, New Jersey, United States
  • Roswell Park Comprehensive Cancer Center Buffalo, New York, United States
View Trial Details
Active, Not Recruiting

The Engaging Primary Care in Cancer Survivorship (EPICS) Study

NCT04745754

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +14 more
Locations
  • Kaiser Permanente Orange County Anaheim/Irvine Medical Center Oncology Clinics Anaheim, California, United States
  • Kaiser Permanente Baldwin Park Medical Center Oncology Clinic Baldwin Park, California, United States
  • Kaiser Permanente Downey/Bellflower Medical Center Oncology Clinics Downey, California, United States
  • Kaiser Permanente Fontana Medical Center Oncology Clinic Fontana, California, United States
View all 13 locations
View Trial Details
Active, Not Recruiting

Study of Cabozantinib in Combination With Atezolizumab Versus Sorafenib in Participants With Advanced Hepatocellular Carcinoma (HCC) Who Have Not Received Previous Systemic Anticancer Therapy

NCT03755791

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • Exelixis Clinical Site #208 Phoenix, Arizona, United States
  • Exelixis Clinical Site #159 Tucson, Arizona, United States
  • Exelixis Clinical Site #44 La Jolla, California, United States
  • Exelixis Clinical Site #112 Los Angeles, California, United States
View all 245 locations
View Trial Details
Active, Not Recruiting

A Study Evaluating Bemarituzumab in Combination With Other Anti-cancer Therapies in Subjects With Previously Untreated Advanced Gastric or Gastroesophageal Junction Cancer.

NCT05322577

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastric Cancer, +7 more
Locations
  • Northport Veterans Affairs Medical Center Northport, New York, United States
  • Fujita Health University Hospital Toyoake-shi, Aichi-ken, Japan
  • Hirosaki University Hospital Hirosaki-shi, Aomori, Japan
  • Chiba University Hospital Chiba, Japan
View all 42 locations
View Trial Details
Active, Not Recruiting

BOXR1030 T Cells in Subjects With Advanced GPC3-Positive Solid Tumors

NCT05120271

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +28 more
Locations
  • Hoag Hospital Newport Beach Newport Beach, California, United States
  • Baylor Scott and White Research Institute Dallas, Texas, United States
  • University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • Fred Hutchinson Cancer Center - Seattle Cancer Care Alliance (SCCA) Location Seattle, Washington, United States
View Trial Details

Related conditions